Real-world outcomes with avelumab + axitinib in patients with advanced renal cell carcinoma in Japan: subgroup analyses from the J-DART2 study by International Metastatic Renal Cell Carcinoma Database Consortium risk classification

Junya Furukawa; Taigo Kato; Toshinari Yamasaki; Keisuke Monji; Toshiaki Tanaka; Norihiko Tsuchiya; Tomoaki Miyagawa; Hiroshi Yaegashi; 八重樫 洋; Tomoyasu Sano; Takashi Karashima; Kazutoshi Fujita; Jun-ichi Hori; Takayuki Ito; Masahiro Kajita; Yoshihiko Tomita; Nobuo Shinohara; Masatoshi Eto; Mototsugu Oya; Hirotsugu Uemura

doi:https://doi.org/10.1007/s10147-024-02655-4

WEKO3

lat lon distance

[[sub_check.contents]]

[[sub_radio.contents]]

Field does not validate

[[sub_attr.contents]]　

インデックスツリー

アイテム

Real-world outcomes with avelumab + axitinib in patients with advanced renal cell carcinoma in Japan: subgroup analyses from the J-DART2 study by International Metastatic Renal Cell Carcinoma Database Consortium risk classification

http://hdl.handle.net/2297/0002004063

名前 / ファイル	ライセンス	アクション
https://doi.org/10.1007/s10147-024-02655-4

アイテムタイプ

itemtype_001(1)

公開日

2026-03-24

タイトル

Real-world outcomes with avelumab + axitinib in patients with advanced renal cell carcinoma in Japan: subgroup analyses from the J-DART2 study by International Metastatic Renal Cell Carcinoma Database Consortium risk classification

言語

作成者

Junya Furukawa
Taigo Kato
Toshinari Yamasaki
Keisuke Monji
Toshiaki Tanaka
Norihiko Tsuchiya
Tomoaki Miyagawa
Hiroshi Yaegashi

e-Rad_Researcher 00835275

	Hiroshi Yaegashi 八重樫洋

Search repository

Tomoyasu Sano
Takashi Karashima
Kazutoshi Fujita
Jun-ichi Hori
Takayuki Ito
Masahiro Kajita
Yoshihiko Tomita
Nobuo Shinohara
Masatoshi Eto
Mototsugu Oya
Hirotsugu Uemura

アクセス権

open access

アクセス権URI

http://purl.org/coar/access_right/c_abf2

内容記述

内容記述タイプ

Other

内容記述

PreKURA:1983

出版者

Springer

言語

eng

資源タイプ

資源タイプ識別子

http://purl.org/coar/resource_type/c_6501

資源タイプ

journal article

出版タイプ

出版タイプResource

http://purl.org/coar/version/c_be7fb7dd8ff6fe43

Versions

Ver.1

2026-03-09 01:45:17.465359

Show All versions

Cite as

Other

エクスポート

OAI-PMH

JPCOAR 2.0
JPCOAR 1.0
DublinCore
DDI

Other Formats

インデックスリンク

インデックスツリー

アイテム

Real-world outcomes with avelumab + axitinib in patients with advanced renal cell carcinoma in Japan: subgroup analyses from the J-DART2 study by International Metastatic Renal Cell Carcinoma Database Consortium risk classification

× Junya Furukawa

× Taigo Kato

× Toshinari Yamasaki

× Keisuke Monji

× Toshiaki Tanaka

× Norihiko Tsuchiya

× Tomoaki Miyagawa

× Hiroshi Yaegashi

× Tomoyasu Sano

× Takashi Karashima

× Kazutoshi Fujita

× Jun-ichi Hori

× Takayuki Ito

× Masahiro Kajita

× Yoshihiko Tomita

× Nobuo Shinohara

× Masatoshi Eto

× Mototsugu Oya

× Hirotsugu Uemura

Versions

Share

Cite as

Other

エクスポート

コミュニティ

メニューを最小化

インデックスリンク

インデックスツリー

アイテム

Real-world outcomes with avelumab + axitinib in patients with advanced renal cell carcinoma in Japan: subgroup analyses from the J-DART2 study by International Metastatic Renal Cell Carcinoma Database Consortium risk classification

× Junya Furukawa

× Taigo Kato

× Toshinari Yamasaki

× Keisuke Monji

× Toshiaki Tanaka

× Norihiko Tsuchiya

× Tomoaki Miyagawa

× Hiroshi Yaegashi

× Tomoyasu Sano

× Takashi Karashima

× Kazutoshi Fujita

× Jun-ichi Hori

× Takayuki Ito

× Masahiro Kajita

× Yoshihiko Tomita

× Nobuo Shinohara

× Masatoshi Eto

× Mototsugu Oya

× Hirotsugu Uemura

Versions

Share

Cite as

Other

エクスポート

コミュニティ